- Home
- AXP vs ABT Comparison
AXP vs ABT Comparison
Compare AXP & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXP
- ABT
- Stock Information
- Founded
- AXP 1850
- ABT 1888
- Country
- AXP United States
- ABT United States
- Employees
- AXP N/A
- ABT N/A
- Industry
- AXP Finance: Consumer Services
- ABT Medical/Dental Instruments
- Sector
- AXP Finance
- ABT Health Care
- Exchange
- AXP Nasdaq
- ABT Nasdaq
- Market Cap
- AXP 218.5B
- ABT 221.0B
- IPO Year
- AXP N/A
- ABT N/A
- Fundamental
- Price
- AXP $295.37
- ABT $134.94
- Analyst Decision
- AXP Hold
- ABT Buy
- Analyst Count
- AXP 22
- ABT 17
- Target Price
- AXP $291.75
- ABT $131.41
- AVG Volume (30 Days)
- AXP 2.4M
- ABT 6.5M
- Earning Date
- AXP 04-17-2025
- ABT 04-16-2025
- Dividend Yield
- AXP 0.95%
- ABT 1.75%
- EPS Growth
- AXP 24.98
- ABT 134.36
- EPS
- AXP 14.01
- ABT 7.64
- Revenue
- AXP $60,764,000,000.00
- ABT $41,950,000,000.00
- Revenue This Year
- AXP N/A
- ABT $6.71
- Revenue Next Year
- AXP $8.22
- ABT $7.45
- P/E Ratio
- AXP $21.08
- ABT $17.70
- Revenue Growth
- AXP 9.30
- ABT 4.59
- 52 Week Low
- AXP $213.25
- ABT $99.71
- 52 Week High
- AXP $326.27
- ABT $135.41
- Technical
- Relative Strength Index (RSI)
- AXP 34.18
- ABT 71.01
- Support Level
- AXP $303.91
- ABT $128.25
- Resistance Level
- AXP $313.69
- ABT $132.65
- Average True Range (ATR)
- AXP 6.41
- ABT 2.43
- MACD
- AXP -2.31
- ABT -0.02
- Stochastic Oscillator
- AXP 5.16
- ABT 95.01
About AXP American Express Company
American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. Since 2018, it has operated in three segments: global consumer services, global commercial services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.